Cargando…
FAM129B is a novel regulator of Wnt/β-catenin signal transduction in melanoma cells
The inability of targeted BRAF inhibitors to produce long-lasting improvement in the clinical outcome of melanoma highlights a need to identify additional approaches to inhibit melanoma growth. Recent studies have shown that activation of the Wnt/β-catenin pathway decreases tumor growth and cooperat...
Autores principales: | Conrad, Willliam, Major, Michael B, Cleary, Michele A, Ferrer, Marc, Roberts, Brian, Marine, Shane, Chung, Namjin, Arthur, William T, Moon, Randall T, Berndt, Jason D, Chien, Andy J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829391/ https://www.ncbi.nlm.nih.gov/pubmed/24358901 http://dx.doi.org/10.12688/f1000research.2-134.v2 |
Ejemplares similares
-
Activation of Wnt/β-Catenin Signaling Increases Apoptosis in Melanoma Cells Treated with Trail
por: Zimmerman, Zachary F., et al.
Publicado: (2013) -
A Re-evaluation of the “Oncogenic” Nature of Wnt/β-catenin Signaling in Melanoma and Other Cancers
por: Lucero, Olivia M., et al.
Publicado: (2010) -
Protein Kinase PKN1 Represses Wnt/β-Catenin Signaling in Human Melanoma Cells
por: James, Richard G., et al.
Publicado: (2013) -
Targeted BRAF Inhibition Impacts Survival in Melanoma Patients with High Levels of Wnt/β-Catenin Signaling
por: Chien, Andy J., et al.
Publicado: (2014) -
WNT7B mediates autocrine Wnt/β-catenin signaling and anchorage-independent growth in pancreatic adenocarcinoma
por: Arensman, Michael D., et al.
Publicado: (2013)